InfuSystem (NYSE:INFU) CEO Carrie Lachance Buys 2,000 Shares

InfuSystem Holdings, Inc. (NYSE:INFU) CEO Carrie Lachance acquired 2,000 shares of the stock in a transaction that occurred on Friday, May 8th. The shares were bought at an average price of $8.83 per share, for a total transaction of $17,660.00. Following the transaction, the chief executive officer owned 237,123 shares of the company’s stock, valued at $2,093,796.09. This trade represents a 0.85% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is available through this hyperlink.

Carrie Lachance also recently made the following trade(s):

• On Monday, May 11th, Carrie Lachance acquired 1,000 shares of InfuSystem stock. The shares were bought at an average price of $8.46 per share, for a total transaction of $8,460.00.

InfuSystem Stock Up 0.5%

Shares of InfuSystem stock opened at $8.41 on Wednesday. The company has a market cap of $169.83 million, a price-to-earnings ratio of 140.19 and a beta of 1.49. The company’s 50 day moving average is $9.67 and its 200 day moving average is $9.20. InfuSystem Holdings, Inc. has a twelve month low of $5.08 and a twelve month high of $11.04. The company has a quick ratio of 1.59, a current ratio of 1.98 and a debt-to-equity ratio of 0.50.

Analyst Upgrades and Downgrades

Separately, Roth Mkm restated a “buy” rating and set a $15.00 price objective (up from $14.00) on shares of InfuSystem in a research report on Tuesday, February 24th. Two equities research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $15.00.

Institutional Trading of InfuSystem

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Dimensional Fund Advisors LP increased its holdings in InfuSystem by 6.0% during the first quarter. Dimensional Fund Advisors LP now owns 594,288 shares of the company’s stock valued at $5,486,000 after buying an additional 33,410 shares during the last quarter. Heartland Advisors Inc. raised its position in shares of InfuSystem by 2.0% during the 1st quarter. Heartland Advisors Inc. now owns 510,000 shares of the company’s stock valued at $4,707,000 after purchasing an additional 10,000 shares during the period. Hillsdale Investment Management Inc. raised its position in shares of InfuSystem by 1.1% during the 1st quarter. Hillsdale Investment Management Inc. now owns 452,373 shares of the company’s stock valued at $4,175,000 after purchasing an additional 5,000 shares during the period. Hsbc Holdings PLC grew its stake in InfuSystem by 5.7% during the first quarter. Hsbc Holdings PLC now owns 30,097 shares of the company’s stock valued at $281,000 after acquiring an additional 1,619 shares in the last quarter. Finally, North Star Investment Management Corp. grew its stake in InfuSystem by 527.6% during the first quarter. North Star Investment Management Corp. now owns 182,000 shares of the company’s stock valued at $1,680,000 after acquiring an additional 153,000 shares in the last quarter. 71.13% of the stock is owned by hedge funds and other institutional investors.

About InfuSystem

InfuSystem Holdings Inc is a medical technology company that specializes in the rental, management and servicing of infusion pumps and associated devices used primarily for outpatient infusion therapy. The company provides a comprehensive suite of services that includes equipment delivery, setup and retrieval, preventive and corrective maintenance, reprocessing and quality assurance. InfuSystem’s offerings are designed to help hospitals, ambulatory surgery centers, oncology clinics and private infusion suites streamline clinical operations and maintain compliance with safety standards.

In addition to pump rental and repair services, InfuSystem has expanded into remote patient monitoring solutions.